According to filings with the U.S. Securities and Exchange Commission, Primrose Bio is raising up to $23,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Helge Zieler played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Primrose Bio
Primrose Bio offers radically new products and tools that unlock unexplored possibilities for the discovery, development, and manufacturing of new molecules. Our mission is to enable the development of innovative therapeutics, vaccines and ingredients to advance global health.

To learn more about Primrose Bio, visit http://primrosebio.com/
Primrose Bio Linkedin Page: https://www.linkedin.com/company/primrose-bio/

Contact:
Helge Zieler, Chief Executive Officer
858-352-4400

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.